drugset

drugset / Trial / NCT01131572

N-acetylcysteine in Bulimia Nervosa

NCT01131572 ↗

Phase 2/3 Terminated 11 enrolled Lindner Center of HOPE

NaSingle-groupOpen-labelTreatment

Summary

This study tests NAC in the treatment of Bulimia Nervosa.

Timeline

Start: 2010-02
Primary completion: 2012-03
Completion: 2012-03

Publications

Results Guerdjikova AI, Blom TJ, Mori N, McElroy SL. N-acetylcysteine in bulimia nervosa--open-label trial. Eat Behav. 2013 Jan;14(1):87-9. doi: 10.1016/j.eatbeh.2012.11.001. Epub 2012 Nov 19.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	N-acetylcysteine	Small molecule	—	—

Indications

No indication recorded.